© 2005 Society for Experimental Biology and Medicine
|
MINIREVIEW |
Robert T. Mallet*1,
Jie Sun*,
E. Marty Knott*,
Arti B. Sharma* and
Albert H. Olivencia-Yurvati
* Departments of Integrative Physiology and Surgery, University of North Texas Health Science Center, Fort Worth, Texas 76107–2699
1 Department of Integrative Physiology, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107–2699. E-mail: malletr{at}hsc.unt.edu
Pyruvate, a natural metabolic fuel and antioxidant in myocardium and other tissues, exerts a variety of cardioprotective actions when provided at supraphysiological concentrations. Pyruvate increases cardiac contractile performance and myocardial energy state, bolsters endogenous antioxidant systems, and protects myocardium from ischemia-reperfusion injury and oxidant stress. This article reviews and discusses basic and clinically oriented research conducted over the last several years that has yielded fundamental information on pyruvate’s inotropic and cardioprotective mechanisms. Particular attention is placed on pyruvate’s enhancement of sarcoplasmic reticular Ca2+ transport, its antioxidantproperties, and its ability to mitigate reversible and irreversiblemyocardial injury. These research efforts are establishing theessential foundation for clinical application of pyruvate therapyin numerous settings including cardiopulmonary bypass surgery,cardiopulmonary resuscitation, myocardial stunning, and cardiacfailure.
Keywords: antioxidant, bypass surgery, cardiac stunning, cardiopulmonary resuscitation, ethyl pyruvate, infarction, myocardial ischemia, phosphorylation potential, reactive oxygen species
This work was supported by grants from the National Heart, Lungand Blood Institute (HL-71684) and the Osteopathic HeritageFoundation (OHF 02-18-522). E.M.K. and A.B.S. were supportedby fellowships from the University of North Texas Health ScienceCenter Graduate School of Biomedical Sciences.
CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What’s this?
This article has been cited by other articles:
S. Li, M.-Q. Zheng, and G. J. Rozanski Glutathione homeostasis in ventricular myocytes from rat hearts with chronic myocardial infarction |
Exp Physiol,
July 1, 2009;
94(7):
815 – 824.
[Abstract]
[Full Text]
[PDF]
A. Drouin and E. Thorin Flow-Induced Dilation Is Mediated by Akt-Dependent Activation of Endothelial Nitric Oxide Synthase-Derived Hydrogen Peroxide in Mouse Cerebral Arteries |
Stroke,
May 1, 2009;
40(5):
1827 – 1833.
[Abstract]
[Full Text]
[PDF]
D. M. Rudd and G. P. Dobson Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation. |
J. Thorac. Cardiovasc. Surg.,
January 1, 2009;
137(1):
198 – 207.
[Abstract]
[Full Text]
[PDF]
A. K. Olson, O. M. Hyyti, G. A. Cohen, X.-H. Ning, M. Sadilek, N. Isern, and M. A. Portman Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion |
Am J Physiol Heart Circ Physiol,
December 1, 2008;
295(6):
H2315 – H2320.
[Abstract]
[Full Text]
[PDF]
E. Nevoigt Progress in Metabolic Engineering of Saccharomyces cerevisiae |
Microbiol. Mol. Biol. Rev.,
September 1, 2008;
72(3):
379 – 412.
[Abstract]
[Full Text]
[PDF]
Q. Gao and M. S. Wolin Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle |
Am J Physiol Heart Circ Physiol,
September 1, 2008;
295(3):
H978 – H989.
[Abstract]
[Full Text]
[PDF]
J. Lee, W. Kwon, Y. Jo, G. Suh, and Y. Youn Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats |
Human and Experimental Toxicology,
January 1, 2008;
27(1):
49 – 54.
[Abstract]
[PDF]
B. Keweloh, P. M.L. Janssen, U. Siegel, N. Datz, O. Zeitz, and H.-P. Hermann Influence of pyruvate on economy of contraction in isolated rabbit myocardium |
Eur J Heart Fail,
August 1, 2007;
9(8):
754 – 761.
[Abstract]
[Full Text]
[PDF]
A. Drouin, N. Thorin-Trescases, E. Hamel, J. R. Falck, and E. Thorin Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries |
Cardiovasc Res,
January 1, 2007;
73(1):
73 – 81.
K. Golman, R. in ‘t Zandt, and M. Thaning Real-time metabolic imaging |
PNAS,
July 25, 2006;
103(30):
11270 – 11275.
[Abstract]
[Full Text]
[PDF]